136 related articles for article (PubMed ID: 36788076)
21. RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer.
Manzano RG; Catalan-Latorre A; Brugarolas A
BMC Cancer; 2021 Apr; 21(1):432. PubMed ID: 33879103
[TBL] [Abstract][Full Text] [Related]
22. Genomic and transcriptomic comparison of post-radiation versus sporadic sarcomas.
Lesluyes T; Baud J; Pérot G; Charon-Barra C; You A; Valo I; Bazille C; Mishellany F; Leroux A; Renard-Oldrini S; Terrier P; Le Cesne A; Laé M; Piperno-Neumann S; Bonvalot S; Neuville A; Collin F; Maingon P; Coindre JM; Chibon F
Mod Pathol; 2019 Dec; 32(12):1786-1794. PubMed ID: 31243333
[TBL] [Abstract][Full Text] [Related]
23. The landscape of genetic aberrations in myxofibrosarcoma.
Takeuchi Y; Yoshida K; Halik A; Kunitz A; Suzuki H; Kakiuchi N; Shiozawa Y; Yokoyama A; Inoue Y; Hirano T; Yoshizato T; Aoki K; Fujii Y; Nannya Y; Makishima H; Pfitzner BM; Bullinger L; Hirata M; Jinnouchi K; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Okamoto T; Haga H; Ogawa S; Damm F
Int J Cancer; 2022 Aug; 151(4):565-577. PubMed ID: 35484982
[TBL] [Abstract][Full Text] [Related]
24. Genetic susceptibility in children, adolescents, and young adults diagnosed with soft-tissue sarcomas.
Würtemberger J; Ripperger T; Vokuhl C; Bauer S; Teichert-von Lüttichau I; Wardelmann E; Niemeyer CM; Kratz CP; Schlegelberger B; Hettmer S
Eur J Med Genet; 2023 May; 66(5):104718. PubMed ID: 36764384
[TBL] [Abstract][Full Text] [Related]
25. A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis.
Bui NQ; Przybyl J; Trabucco SE; Frampton G; Hastie T; van de Rijn M; Ganjoo KN
Clin Sarcoma Res; 2019; 9():12. PubMed ID: 31528332
[TBL] [Abstract][Full Text] [Related]
26. Molecular signatures of BRCAness analysis identifies PARP inhibitor Niraparib as a novel targeted therapeutic strategy for soft tissue Sarcomas.
Li H; Tu J; Zhao Z; Chen L; Qu Y; Li H; Yao H; Wang X; Lee DF; Shen J; Wen L; Huang G; Xie X
Theranostics; 2020; 10(21):9477-9494. PubMed ID: 32863940
[No Abstract] [Full Text] [Related]
27. Genomic Profiling of Radiation-Induced Sarcomas Reveals the Immunologic Characteristics and Its Response to Immune Checkpoint Blockade.
Hong DC; Yang J; Sun C; Liu YT; Shen LJ; Xu BS; Que Y; Xia X; Zhang X
Clin Cancer Res; 2023 Aug; 29(15):2869-2884. PubMed ID: 37184976
[TBL] [Abstract][Full Text] [Related]
28. Somatic and Germline
Sherborne AL; Lavergne V; Yu K; Lee L; Davidson PR; Mazor T; Smirnoff IV; Horvai AE; Loh M; DuBois SG; Goldsby RE; Neglia JP; Hammond S; Robison LL; Wustrack R; Costello JF; Nakamura AO; Shannon KM; Bhatia S; Nakamura JL
Clin Cancer Res; 2017 Apr; 23(7):1852-1861. PubMed ID: 27683180
[No Abstract] [Full Text] [Related]
29. Identification of germline cancer predisposition variants in pediatric sarcoma patients from somatic tumor testing.
Alba-Pavón P; Alaña L; Gutierrez-Jimeno M; García-Obregón S; Imízcoz T; Panizo E; González-Urdiales P; Echebarria-Barona A; Lopez Almaraz R; Zaldumbide L; Astigarraga I; Patiño-García A; Villate O
Sci Rep; 2023 Feb; 13(1):2959. PubMed ID: 36805510
[TBL] [Abstract][Full Text] [Related]
30. High frequency of MYC gene amplification is a common feature of radiation-induced sarcomas. Further results from EORTC STBSG TL 01/01.
Käcker C; Marx A; Mössinger K; Svehla F; Schneider U; Hogendoorn PC; Nielsen OS; Küffer S; Sauer C; Fisher C; Hallermann C; Hartmann JT; Blay JY; Mechtersheimer G; Hohenberger P; Ströbel P
Genes Chromosomes Cancer; 2013 Jan; 52(1):93-8. PubMed ID: 23012233
[TBL] [Abstract][Full Text] [Related]
31. Integrated mutational landscape analysis of uterine leiomyosarcomas.
Choi J; Manzano A; Dong W; Bellone S; Bonazzoli E; Zammataro L; Yao X; Deshpande A; Zaidi S; Guglielmi A; Gnutti B; Nagarkatti N; Tymon-Rosario JR; Harold J; Mauricio D; Zeybek B; Menderes G; Altwerger G; Jeong K; Zhao S; Buza N; Hui P; Ravaggi A; Bignotti E; Romani C; Todeschini P; Zanotti L; Odicino F; Pecorelli S; Ardighieri L; Bilguvar K; Quick CM; Silasi DA; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Imielinski M; Schwartz PE; Alexandrov LB; Lifton RP; Schlessinger J; Santin AD
Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33876771
[TBL] [Abstract][Full Text] [Related]
32. Non-homologous end-joining genes are not inactivated in human radiation-induced sarcomas with genomic instability.
Lefèvre SH; Coquelle A; Gonin-Laurent N; Cör A; Vogt N; Chauveinc L; Anract P; Dutrillaux B; Chevillard S; Malfoy B
J Radiat Res; 2005 Jun; 46(2):223-31. PubMed ID: 15988141
[TBL] [Abstract][Full Text] [Related]
33. Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families.
Van Marcke C; Helaers R; De Leener A; Merhi A; Schoonjans CA; Ambroise J; Galant C; Delrée P; Rothé F; Bar I; Khoury E; Brouillard P; Canon JL; Vuylsteke P; Machiels JP; Berlière M; Limaye N; Vikkula M; Duhoux FP
Breast Cancer Res; 2020 Apr; 22(1):36. PubMed ID: 32295625
[TBL] [Abstract][Full Text] [Related]
34. TP53 in bone and soft tissue sarcomas.
Thoenen E; Curl A; Iwakuma T
Pharmacol Ther; 2019 Oct; 202():149-164. PubMed ID: 31276706
[TBL] [Abstract][Full Text] [Related]
35. Sarcoma and the 100,000 Genomes Project: our experience and changes to practice.
Prendergast SC; Strobl AC; Cross W; Pillay N; Strauss SJ; Ye H; Lindsay D; Tirabosco R; Chalker J; Mahamdallie SS; Sosinsky A; ; ; Flanagan AM; Amary F
J Pathol Clin Res; 2020 Oct; 6(4):297-307. PubMed ID: 32573957
[TBL] [Abstract][Full Text] [Related]
36. Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations.
Tirode F; Surdez D; Ma X; Parker M; Le Deley MC; Bahrami A; Zhang Z; Lapouble E; Grossetête-Lalami S; Rusch M; Reynaud S; Rio-Frio T; Hedlund E; Wu G; Chen X; Pierron G; Oberlin O; Zaidi S; Lemmon G; Gupta P; Vadodaria B; Easton J; Gut M; Ding L; Mardis ER; Wilson RK; Shurtleff S; Laurence V; Michon J; Marec-Bérard P; Gut I; Downing J; Dyer M; Zhang J; Delattre O;
Cancer Discov; 2014 Nov; 4(11):1342-53. PubMed ID: 25223734
[TBL] [Abstract][Full Text] [Related]
37. Two classes of intrahepatic cholangiocarcinoma defined by relative abundance of mutations and copy number alterations.
Kim YH; Hong EK; Kong SY; Han SS; Kim SH; Rhee JK; Hwang SK; Park SJ; Kim TM
Oncotarget; 2016 Apr; 7(17):23825-36. PubMed ID: 27009864
[TBL] [Abstract][Full Text] [Related]
38. Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract.
Wu H; Yu Z; Liu Y; Guo L; Teng L; Guo L; Liang L; Wang J; Gao J; Li R; Yang L; Nie X; Su D; Liang Z
Cancer Commun (Lond); 2022 Dec; 42(12):1367-1386. PubMed ID: 36264285
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.
;
Cell; 2017 Nov; 171(4):950-965.e28. PubMed ID: 29100075
[TBL] [Abstract][Full Text] [Related]
40. Spectra and characteristics of somatic mutations induced by ionizing radiation in hematopoietic stem cells.
Matsuda Y; Uchimura A; Satoh Y; Kato N; Toshishige M; Kajimura J; Hamasaki K; Yoshida K; Hayashi T; Noda A; Tanabe O
Proc Natl Acad Sci U S A; 2023 Apr; 120(15):e2216550120. PubMed ID: 37018193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
